Vanda Bertolli

Late-onset progressive multifocal leukoencephalopathy after teclistamab in multiple myeloma: extending the timeline of infectious risk

Davide Chizzoniti, Fabrizio Ciambelli, Maria Luisa Latargia, Luca Canziani et autres

Not available.

it, cr (code pays fourni par la source)

Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy

Alessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, Chiara Elena et autres

INTRODUCTION: Up to 30% of CML patients will require a therapeutic change during follow-up due to intolerance and/or resistance to first-line tyrosine kinase inhibitor (TKI) approach. In this context, bosutinib (BOS) has not only demonstrated its efficacy, but also presents a favorable …

it (code pays fourni par la source)

Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma

Lorena Appio, Carlo Landoni, Maria La Targia, Vanda Bertolli et autres

Aggressive non-Hodgkin lymphoma is associated with poor long-term survival after relapse or resistance to chemotherapy. We report a case of aggressive non-Hodgkin lymphoma refractory to first-line R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) and second-line R-DHAP (rituximab, dexamethasone, cytarabine, and cisplatin) chemotherapy …

us, it (code pays fourni par la source)

GM-CSF mouthrinses in the treatment of severe oral mucositis: A pilot study

Cristina Bez, Federica Demarosi, Andrea Sardella, Giovanni Lodi et autres

it (code pays fourni par la source)

Cytogenetic and myelodysplastic alterations after autologous hemopoietic stem cell transplantation

C. Annaloro, E Pozzoli, Alessandro Oriani, Aldo Della Volpe et autres

it (code pays fourni par la source)

Autologous Bone Marrow Transplantation in Advanced Hodgkin's Disease

C. Annaloro, E Pozzoli, Aldo Della Volpe, Alessandro Oriani et autres

Autologous bone marrow transplantation (ABMT) has been proposed as an alternative treatment of resistant/refractory Hodgkin's disease (HD). Thirty-seven patients in various phases of HD underwent autografting in our Center: fourteen received a CBV conditioning regimen, the others BCNU or VP16 followed by …

it (code pays fourni par la source)